Method operable design region for robust RP-HPLC analysis of pioglitazone hydrochloride and teneligliptin hydrobromide hydrate: incorporating hybrid principles of white analytical chemistry and design of experiments

Method operable design region for robust RP-HPLC analysis of pioglitazone hydrochloride and teneligliptin hydrobromide hydrate: incorporating hybrid principles of white analytical chemistry and design of experiments

Abstract Background A combination of pioglitazone hydrochloride with teneligliptin hydrobromide hydrate is used to treat type-2 diabetes. Several chromatographic techniques have been described in the literature for determination of each of these medications separately. But these procedures used orga...

Full description

Bibliographic Details
Main Authors: Pintu Prajapati, Bageshree Rana, Veera Shakar Pulusu, Shailesh Shah
Format: Article
Language:English
Published: SpringerOpen 2023-10-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Teneligliptin hydrobromide hydrate
Pioglitazone hydrochloride
White analytical chemistry
Design of experiments
Analytical quality by design
Online Access:https://doi.org/10.1186/s43094-023-00546-5

Internet

https://doi.org/10.1186/s43094-023-00546-5

Similar Items